U.S. Interactive Media and Services Stock News

With legal immigration approvals falling sharply, student visas under pressure, and labor costs facing upward strain, many investors are looking at automation and productivity-focused stocks as potential ways to gain exposure to companies that may be better placed when skilled labor is harder to secure. This article looks at how that backdrop links to a U.S. Domestic Automation and Productivity-Enhancing Technology Stocks screener. It also reveals 3 stocks that screen well on business health...

In June 2026, Graphic Packaging Holding Company stockholders approved amendments to declassify the board over three years and allow stockholders holding 25% of shares to call special meetings, while a securities class action was filed alleging false and misleading statements about inventory issues, demand, costs, and financial guidance. Together with the retirement of long-time Chairman Philip Martens and the election of Larry Venturelli as Chairman, these governance and legal developments...

Republic Services (RSG) is in focus after recent weakness, with the stock down about 2% over the past month and roughly 5% over the past 3 months, prompting closer attention from investors seeking income and stability. See our latest analysis for Republic Services. At a share price of $204.36, Republic Services has seen its short term share price momentum fade, with the 7 day and 90 day share price returns both down, while the 3 year total shareholder return of 43.20% and 5 year total...

Zymeworks recently reported Phase 1 data for its folate receptor alpha-targeting ADC ZW191, showing meaningful anti-tumor activity and a manageable safety profile in platinum-resistant ovarian and endometrial cancer patients across both FRa-positive and FRa-negative tumors. The breadth of responses regardless of FRa expression level suggests ZW191 could potentially widen the use of FRa-directed therapies beyond the narrow biomarker-defined populations targeted by current options. We’ll now...

Insulet recently reported past clinical trial data at the American Diabetes Association’s 86th Scientific Sessions showing its Omnipod 6 and a fully closed-loop type 2 diabetes system improved time in tight range and delivered up to 50% more automated insulin while reducing manual boluses. These results, along with management’s plan to commercialize the fully closed-loop system by 2028, highlight Insulet’s push to extend its tubeless automated insulin delivery technology into broader and...

ITT (ITT) is back in focus after reporting quarterly revenue growth that topped analyst expectations and announcing a deal to acquire Aerospace Contacts LLC, a move intended to expand its aerospace and defense exposure. See our latest analysis for ITT. Investors have been rewarding ITT’s growth story, with the share price at $199.23 and a year to date share price return of 14.36% sitting alongside a 1 year total shareholder return of 30.96%. This extends to 132.25% over 3 years and suggests...

Reliance Stock Snapshot After Recent Performance Shift Reliance (RS) has drawn fresh attention after a strong run, with the stock last closing at $403.49. That move has investors reassessing how current returns line up with the company’s fundamentals and valuation. See our latest analysis for Reliance. Recent trading has been choppy, with a 1-day share price return of 1.80% and a 7-day share price return that slipped 0.60%. However, the 30-day and 90-day share price returns of 9.94% and...

Teledyne Technologies (TDY) is back in focus after first quarter 2026 results beat analyst expectations and coincided with new defense and thermal imaging product launches, raising fresh questions about what the current share price reflects. See our latest analysis for Teledyne Technologies. The latest Q1 beat and new defense and thermal imaging launches come after a strong run, with Teledyne Technologies’ 1-year total shareholder return of 25.59% outpacing its 18.87% year to date share price...

On June 15, 2026, Prudential Financial completed and announced several senior unsecured fixed-rate note offerings totaling about US$18.83 million, with maturities ranging from 2031 to 2036 and coupons between 4.65% and 5.10%. Around the same time, Prudential released new research on artificial intelligence in workplace benefits, highlighting a sizable trust gap between enthusiastic employers and more cautious employees. We’ll now examine how Prudential’s fresh bond issuance and AI-led...

Old Second Bancorp (OSBC) stock is back in focus after director Dennis Klaeser resigned from the boards of both the holding company and Old Second National Bank on June 5, 2026. See our latest analysis for Old Second Bancorp. The boardroom change comes at a time when Old Second Bancorp’s share price has been firming, with a 30 day share price return of 4.74% and a year to date share price return of 13.35%. The 1 year total shareholder return stands at 30.28% and the 5 year total shareholder...

Moleaer and Xylem recently announced a collaboration to deploy chemical-free nanobubble water treatment technology to municipalities, agencies, and lake management professionals tackling harmful algal blooms and degraded water bodies. By linking Moleaer’s high-capacity nanobubble systems with Xylem’s long-established YSI water quality monitoring platform, the partnership pairs real-time diagnostics with restorative treatment in a single, data-informed offering. Next, we’ll examine how this...

Avis Budget Group (CAR) drew investor attention after-hours as its stock moved higher following the announcement of a $650 million cash settlement with hedge fund Pentwater Capital Management, resolving a long-running short-swing profits dispute. See our latest analysis for Avis Budget Group. The settlement headline follows a strong run in Avis Budget Group's stock, with a 90 day share price return of 58.55% and a 5 year total shareholder return of 150.69%. However, the 3 year total...

On June 11, 2026, Victoria’s Secret & Co. announced that shareholders had preliminarily re-elected all nine director nominees, including Independent Chair Donna James, with final voting results to be confirmed in a forthcoming Form 8-K filing. The strong board endorsement underscores investor confidence in management’s “Path to Potential” strategy, which the company says has driven better-than-guided first-quarter 2026 performance and business momentum. We’ll now examine how this clear...

Earlier in June 2026, Herbalife launched its “Fuel Like Ronaldo” campaign with elite footballer Cristiano Ronaldo, offering a simple four-step framework, prepare, perform, recover, repeat, to turn high-performance sports nutrition into everyday wellness guidance. This collaboration signals Herbalife’s push to connect its brand more directly with mainstream fitness and lifestyle consumers by translating elite-level routines into accessible daily habits. We’ll now explore how the “Fuel Like...

Recent analyst upgrades for Nordson (NDSN), tied to strong backlog growth, better-than-expected earnings, and a long record of dividend increases, have drawn more attention to how the stock’s fundamentals line up today. See our latest analysis for Nordson. Nordson’s recent analyst upgrades sit against a solid price backdrop, with the share price at US$295.06 after a 22.42% year to date share price return and a 40.33% 1 year total shareholder return. This suggests momentum has been building as...

Baker Hughes (BKR) drew fresh attention after securing a lifecycle services award from ANOH Gas Processing Company in Nigeria, covering maintenance, repairs and digital monitoring for turbomachinery at the greenfield ANOH Gas Processing Plant. See our latest analysis for Baker Hughes. Recent announcements like the ANOH lifecycle services award and Baker Hughes’s Jefferies Energy Conference appearance have come alongside a 1-year total shareholder return of 59.06%. At the same time, the 30-day...

In recent weeks, CVS Health has expanded its support for GLP-1 medications through new $49 MinuteClinic virtual evaluations, enhanced pharmacy guidance, and participation from July 1, 2026 in the Medicare GLP-1 Bridge program, while also advancing automation, AI-enabled health platforms, sustainability initiatives, and community health partnerships. These moves highlight CVS Health's push to deepen its role in chronic disease management and tech-enabled care, potentially reinforcing its...

Agios Pharmaceuticals recently filed a US$66.16 million shelf registration for 2,000,000 common shares tied to an employee stock ownership plan and, earlier this month, presented 52-week Phase 3 RISE UP data for mitapivat in sickle cell disease at the European Hematology Association Congress. The newly disclosed analyses showed mitapivat was associated with clinically meaningful reductions in transfusion burden and stronger outcomes among hemoglobin responders, adding important detail beyond...

Wayfair (W) is expanding its physical retail presence with a planned large format store in Princeton, New Jersey. This gives investors another data point on how the company is pursuing omnichannel growth. See our latest analysis for Wayfair. Wayfair's latest store announcement comes after a sharp 30 day share price return of 26.79% and a 12.79% gain over 90 days. The year to date share price is down 20.20%, and the 1 year total shareholder return is 74.01%. This suggests recent momentum has...

Global tech stocks are under pressure after sharp sell-offs in Asian markets and renewed doubts about how sustainable the AI boom really is. When fast growing sectors stumble, many investors look more closely at companies in areas like consumer staples, utilities, and healthcare that pay consistent dividends and can sometimes behave differently to high growth tech stocks. This article focuses on three dividend stocks from the Defensive Dividend Stocks screener that appear closely linked to...

Inflation at 4.2%, a 36.6% jump in producer energy costs, and a possible Federal Reserve rate hike by 2026 have put large U.S. growth stocks under a new kind of spotlight. At the same time, easing oil prices and progress in U.S. Iran peace talks could reduce pressure on future rate moves. For investors, this mix of higher rate risk and potential relief creates both opportunity and reasons for caution. This article walks through 3 large cap growth stocks from our screener that appear...

What Morgan Stanley’s Downgrade Signals for Cleveland-Cliffs Stock Morgan Stanley’s downgrade of Cleveland-Cliffs (CLF) from Overweight to Equal-weight, framed around concerns that recent steel price gains and the stock’s valuation already reflect much of the upside, has drawn fresh attention from investors. See our latest analysis for Cleveland-Cliffs. Cleveland-Cliffs’ share price has pulled back recently, with a 3.18% one day decline and a 12.77% drop over the past week. However, the 90...

If you are wondering whether Barrick Mining is still attractively priced after its strong run, this article focuses squarely on what the current share price suggests about value. The stock recently closed at US$40.14, with the share price falling 4.0% over the past week and 1.3% over the past month, but still up 8.9% year to date, 93.8% over the past year, 159.5% over three years, and 123.3% over five years. Recent coverage around Barrick Mining has highlighted company developments and...

AbbVie (NYSE:ABBV) agreed to acquire Apogee Therapeutics in a cash deal valued at about US$10.9b. The transaction is described as AbbVie's largest acquisition in more than five years. The deal adds clinical-stage programs targeting immunology and respiratory diseases, including zumilokibart for atopic dermatitis and asthma. For investors watching AbbVie, this US$10.9b move adds fresh attention to its immunology and respiratory disease efforts. The company is acquiring Apogee Therapeutics to...